183 related articles for article (PubMed ID: 26011816)
1. Differences between Mitiglinide/Voglibose Fixed-dose Combination and Glimepiride in Modifying Low-density Lipoprotein Heterogeneity in Japanese Type-2 Diabetic Patients: A Pilot Study.
Tani S; Nagao K; Hirayama A
Drug Res (Stuttg); 2016 Feb; 66(2):94-9. PubMed ID: 26011816
[TBL] [Abstract][Full Text] [Related]
2. Glucose excursions and hypoglycemia in patients with type 2 diabetes treated with mitiglinide/voglibose versus glimepiride: A randomized cross-over trial.
Fujimoto K; Shibayama Y; Yamaguchi E; Honjo S; Hamasaki A; Hamamoto Y
J Diabetes; 2018 Aug; 10(8):675-682. PubMed ID: 29493100
[TBL] [Abstract][Full Text] [Related]
3. Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus.
Inoue M
Expert Opin Pharmacother; 2012 Nov; 13(16):2257-68. PubMed ID: 22994875
[TBL] [Abstract][Full Text] [Related]
4. Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus.
Ono Y; Kameda H; Cho KY
Expert Opin Pharmacother; 2013 Mar; 14(4):361-70. PubMed ID: 23414242
[TBL] [Abstract][Full Text] [Related]
5. Glycemic/metabolic responses to identical meal tolerance tests at breakfast, lunch and dinner in Japanese patients with type 2 diabetes mellitus treated with a dipeptidyl peptidase-4 inhibitor and the effects of adding a mitiglinide/voglibose fixed-dose combination.
Ono Y; Kamoshima H; Nakamura A; Nomoto H
Expert Opin Pharmacother; 2014 Sep; 15(13):1785-95. PubMed ID: 25046055
[TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized, multicenter trial comparing the efficacy and safety of the concurrent use of long-acting insulin with mitiglinide or voglibose in patients with type 2 diabetes.
Son JW; Lee IK; Woo JT; Baik SH; Jang HC; Lee KW; Cha BS; Sung YA; Park TS; Yoo SJ; Yoon KH
Endocr J; 2015; 62(12):1049-57. PubMed ID: 26411328
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis.
Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K
Expert Opin Pharmacother; 2010 Feb; 11(2):169-76. PubMed ID: 20025554
[TBL] [Abstract][Full Text] [Related]
8. Effects of sitagliptin or mitiglinide as an add-on to acarbose on daily blood glucose fluctuations measured by 72 h subcutaneous continuous glucose monitoring in Japanese patients with type 2 diabetes: a prospective randomized study.
Osonoi T; Saito M; Tamasawa A; Ishida H; Osonoi Y
Expert Opin Pharmacother; 2014 Jul; 15(10):1325-35. PubMed ID: 24866329
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial.
Tanaka K; Okada Y; Umezu S; Hashimoto R; Tomoyose Y; Tateyama R; Hori Y; Saito M; Tokutsu A; Sonoda S; Uemura F; Kurozumi A; Tanaka Y
J Diabetes Investig; 2024 Apr; 15(4):449-458. PubMed ID: 38149694
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Efficacy of Repaglinide Versus the Combination of Mitiglinide and Voglibose on Glycemic Variability in Japanese Patients with Type 2 Diabetes.
Okada H; Tanaka M; Hasegawa G; Nakajima H; Kadono M; Okada Y; Hirata A; Oyamada H; Yamane T; Fukui M
Curr Pharm Des; 2020; 25(43):4600-4605. PubMed ID: 31538887
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes.
Ohta A; Ohshige T; Sakai K; Nakamura Y; Tenjin A; Tsukiyama S; Terashima Y; Matsubara F; Kawata T; Nagai Y; Tanaka Y
Expert Opin Pharmacother; 2013 Dec; 14(17):2315-22. PubMed ID: 24079645
[TBL] [Abstract][Full Text] [Related]
12. Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus.
Ihana-Sugiyama N; Yamamoto-Honda R; Sugiyama T; Tsujimoto T; Kakei M; Noda M
Med Sci Monit Basic Res; 2017 Feb; 23():36-44. PubMed ID: 28242866
[TBL] [Abstract][Full Text] [Related]
13. [Fixed-dose combination].
Nagai Y
Nihon Rinsho; 2015 Mar; 73(3):465-9. PubMed ID: 25812374
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension.
Kadowaki T; Kondo K
Diabetes Obes Metab; 2014 May; 16(5):418-25. PubMed ID: 24205974
[TBL] [Abstract][Full Text] [Related]
16. Effects of mitiglinide, a short-acting insulin secretagogue, on daily glycemic variability and oxidative stress markers in Japanese patients with type 2 diabetes mellitus.
Kodani N; Saisho Y; Tanaka K; Kawai T; Itoh H
Clin Drug Investig; 2013 Aug; 33(8):563-70. PubMed ID: 23797928
[TBL] [Abstract][Full Text] [Related]
17. Comparison Between Effectiveness of 100 mg/day Sitagliptin and a Switch to Mitiglinide Calcium Hydrate/Voglibose from 50 mg/day Sitagliptin in Patients with Type 2 Diabetes.
Arao T; Okada Y; Torimoto K; Sugai K; Otsuka T; Kurozumi A; Tanaka Y
J UOEH; 2017; 39(1):1-9. PubMed ID: 28331117
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of adding once- and thrice-daily voglibose in Japanese type 2 diabetic patients treated with alogliptin.
Takahara M; Shiraiwa T; Katakami N; Kaneto H; Matsuoka TA; Shimomura I
Endocr J; 2014; 61(5):447-56. PubMed ID: 24561488
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of pioglitazone with voglibose improves glycemic control safely and rapidly in Japanese type 2-diabetic patients on hemodialysis.
Abe M; Kikuchi F; Kaizu K; Matsumoto K
Clin Nephrol; 2007 Nov; 68(5):287-94. PubMed ID: 18044260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
